BUILDING A GLOBAL CONSORTIUM WITH COLLEAGUES IN AFRICA
With TNBC discriminately affecting women of African origin more than any other ancestral group, it is of paramount importance to build collaborations with colleagues in Africa, where the fruits of our research will arguably have most impact. Working with scientists in Nigeria, ICART partners across the globe will come together to advance knowledge and understanding of TNBC, with the goal to improve treatment outcomes for women around the world.
ICART Partner Laboratories in Africa
-
KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY, Kumasi , Ghana
-
OLABISI ONABANJO UNIVERSITY, Sagamu, Nigeria
-
ME CURE HEALTHCARE LIMITED, Oshodi, Nigeria
-
LAGOS UNIVERSITY TEACHING HOSPITAL (LUTH), Idi-Araba, Nigeria
-
LAGOS STATE UNIVERSITY TEACHING HOSPITAL (LASUTH), Ikeja, Nigeria
-
OBAFEMI AWOLOWO UNIVERSITY, Ile-Ife, Nigeria
-
EKITI STATE UNIVERSITY, Ado-Ekiti, Nigeria
-
UNIVERSITY OF BENIN, Benin City, Nigeria
-
CHUKWUEMEKA ODUMEGWU OJUKWU UNIVERSITY, Uli, Nigeria
-
NATIONAL HOSPITAL, Abuja, Nigeria
-
AHMADU BELLO UNIVERSITY, Zaria, Nigeria
-
UNIVERSITY OF JOS, Jos, Nigeria
-
BENUE STATE UNIVERSITY, Makurdi, Nigeria
-
UNIVERSITY OF UYO, Uyo, Nigeria
-
UNIVERSITY OF MADUGURI, Maiduguri, Nigeria
Gallery
Dr. Daramola’s group, Lagos University Teaching Hospital, Nigeria
Ekiti State University, Nigeria
ICART Triple Negative Breast Cancer Research Workshop, July 2016, OOUTH, Nigeria
Dr. Daramola’s group, Lagos University Teaching Hospital, Nigeria
Ekiti State University, Nigeria
ICART Triple Negative Breast Cancer Research Workshop, July 2016, OOUTH, Nigeria